Acceptability of a Nurse-led Telehealth Remote Self-monitoring Model of Care in Patients With Rheumatoid Arthritis

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCHU de Quebec-Universite Laval

About this trial

Canada urgently needs new ways to provide rheumatology care that improve treatment and make it easier for people to get high-quality care. E-health technology is a new and promising way to do this, but it hasn't been studied much yet in rheumatology.

The investigators will test a new way to help people with rheumatoid arthritis at four clinics in Quebec. This study will check if the new approach is easy to use, fits well into the clinics' daily routine, and if both patients and healthcare workers find it helpful and acceptable.

This new approach involves nurses helping patients check their own health from home using an online platform.

104 adults who have rheumatoid arthritis and who have had a flare-up or a change in their medication in the last three months, will participate. Some will start using the online self-monitoring tool right away for 16 months, while others will continue with their usual care for 8 months before trying the tool. During the time they use the tool, they will fill out monthly online questionnaires to check their health. A rheumatology nurse will review their answers, suggest any needed care, provide personalized health information, and be available to answer questions through messages.

This new way of care, where nurses help patients monitor their rheumatoid arthritis from home, helps make better use of limited specialist time. It's more convenient for patients, especially those who live far away, and helps meet their needs between regular doctor visits while keeping the quality of care high.

Eligibility criteria

Qualifiers

Age ≥ 18 years

Diagnosis of rheumatoid arthritis (RA) according to the ACR 2010 criteria

Disease duration ≥ six months

Who experienced a flare defined by an increase of the clinical disease activity index (CDAI) ≥ 4.5 or a DMARDs switch or addition within the preceding three months

Disqualifiers

Inability to consent

Inability to complete questionnaires

No Internet access

Trial design

Treatments tested in this trial

  • Nurse-led telehealth remote self-monitoring

Treatment groups

104 Participants
are divided into 2 treatment groups

Sponsors and collaborators

CHU de Quebec-Universite Laval

Lead sponsor

The Arthritis Society, Canada

Collaborator